William Blair Brokers Lower Earnings Estimates for USPH

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at William Blair cut their Q3 2025 earnings per share estimates for U.S. Physical Therapy in a research note issued to investors on Monday, August 11th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $0.68 for the quarter, down from their previous estimate of $0.70. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s FY2025 earnings at $2.45 EPS and FY2027 earnings at $3.23 EPS.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. The business had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. The business’s revenue was up 18.0% compared to the same quarter last year. During the same period last year, the business posted $0.73 EPS.

A number of other brokerages also recently issued reports on USPH. Wall Street Zen raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. JMP Securities restated a “market outperform” rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Barrington Research upped their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a research report on Friday, August 8th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Price Performance

USPH opened at $85.92 on Thursday. The firm has a market capitalization of $1.31 billion, a PE ratio of 37.52, a price-to-earnings-growth ratio of 4.52 and a beta of 1.45. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.17. The business’s 50-day moving average is $77.39 and its two-hundred day moving average is $77.06. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $101.19.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds and other institutional investors have recently made changes to their positions in USPH. Point72 Asset Management L.P. acquired a new position in U.S. Physical Therapy in the fourth quarter valued at approximately $18,886,000. Nuveen LLC purchased a new position in shares of U.S. Physical Therapy during the 1st quarter valued at approximately $8,702,000. Bahl & Gaynor Inc. lifted its stake in shares of U.S. Physical Therapy by 32.6% in the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock valued at $24,964,000 after purchasing an additional 84,878 shares during the period. Copeland Capital Management LLC boosted its holdings in U.S. Physical Therapy by 8.9% during the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock worth $69,499,000 after buying an additional 72,463 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in U.S. Physical Therapy during the fourth quarter worth $6,240,000.

Insider Activity at U.S. Physical Therapy

In related news, Director Nancy Ham sold 400 shares of the company’s stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the transaction, the director directly owned 2,594 shares of the company’s stock, valued at $202,357.94. This represents a 13.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Graham D. Reeve sold 1,792 shares of the firm’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the transaction, the chief operating officer owned 22,246 shares of the company’s stock, valued at $1,925,836.22. This trade represents a 7.45% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy’s payout ratio is currently 78.60%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.